ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.122,25
0,95%
S&P 500
5.064,20
0,91%
US Dollar vs BRL
5,1104
-1,65%
Bitcoin
58.816,18
0,99%
Brent Oil
83,68
0,17%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Agile Therapeutics Inc (AGRX)

  7. Agile Therapeutics Inc (AGRX) Notícias

AGRX

Agile Therapeutics (AGRX)

Agile Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AGRX
DataHoraFonteTítuloCódigoCompanhia
28/03/202409:05GlobeNewswire Inc.Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:AGRXAgile Therapeutics Inc
25/03/202417:30GlobeNewswire Inc.Agile Therapeutics Announces Delisting from NasdaqNASDAQ:AGRXAgile Therapeutics Inc
21/03/202407:35GlobeNewswire Inc.Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024NASDAQ:AGRXAgile Therapeutics Inc
20/03/202409:15GlobeNewswire Inc.Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024NASDAQ:AGRXAgile Therapeutics Inc
13/03/202408:31GlobeNewswire Inc.Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan ExecutionNASDAQ:AGRXAgile Therapeutics Inc
23/02/202418:57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:AGRXAgile Therapeutics Inc
22/02/202411:01GlobeNewswire Inc.Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross ProceedsNASDAQ:AGRXAgile Therapeutics Inc
15/02/202418:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGRXAgile Therapeutics Inc
15/02/202418:30GlobeNewswire Inc.Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance UpdateNASDAQ:AGRXAgile Therapeutics Inc
13/02/202422:02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
07/02/202418:51Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
23/01/202411:29GlobeNewswire Inc.The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without CostNASDAQ:AGRXAgile Therapeutics Inc
12/12/202310:01GlobeNewswire Inc.Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage RequirementNASDAQ:AGRXAgile Therapeutics Inc
11/12/202319:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:AGRXAgile Therapeutics Inc
09/11/202318:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AGRXAgile Therapeutics Inc
09/11/202310:05GlobeNewswire Inc.Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:AGRXAgile Therapeutics Inc
26/10/202309:05GlobeNewswire Inc.Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023NASDAQ:AGRXAgile Therapeutics Inc
04/10/202317:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGRXAgile Therapeutics Inc
04/10/202317:30GlobeNewswire Inc.Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AGRXAgile Therapeutics Inc
05/09/202309:05GlobeNewswire Inc.Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:AGRXAgile Therapeutics Inc
25/08/202317:02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AGRXAgile Therapeutics Inc
22/08/202309:30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
09/08/202309:05GlobeNewswire Inc.Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:AGRXAgile Therapeutics Inc
26/07/202309:30GlobeNewswire Inc.Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023NASDAQ:AGRXAgile Therapeutics Inc
27/06/202317:47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
26/06/202309:01GlobeNewswire Inc.Agile Therapeutics Announces the Availability of Twirla® to MMCAP Infuse MembersNASDAQ:AGRXAgile Therapeutics Inc
23/06/202313:05GlobeNewswire Inc.Agile Therapeutics Commends the Biden Administration’s Commitment to Strengthening Access to Affordable, High-Quality Contraception and Family Planning ServicesNASDAQ:AGRXAgile Therapeutics Inc
15/06/202317:05GlobeNewswire Inc.Agile Therapeutics Announces the Availability of Twirla® through FPA Women’s HealthNASDAQ:AGRXAgile Therapeutics Inc
14/06/202317:36Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AGRXAgile Therapeutics Inc
13/06/202317:05GlobeNewswire Inc.Agile Therapeutics Announces New Agreement with vitaCare® Prescription Services to Improve Access to Twirla®NASDAQ:AGRXAgile Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AGRX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
ENJU3
Enjoei ON
BOV
AZEV4
AZEVEDO PN
BOV
HBOR3
HELBOR ON
BOV
PRIO3
PETRORIO ON
BOV
ZAMP3
Zamp ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
COGN3
COGNA ON
BOV
RSID3
ROSSI RESID ON
BOV
HAGA3
HAGA ON
BOV
POMO4
MARCOPOLO PN
BOV
BHIA3
Grupo Casas Bahia ON
BOV
OIBR3
OI ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
TECN3
TECHNOS ON
BOV
TELB4
TELEBRAS PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados